Table 1 Clinical and demographic properties of two groups.
Variable | Cardiovascular death group (n = 24) | Survival group (n = 157) | P value |
|---|---|---|---|
Age (years) | 68.19 ± 10.72 | 63.57 ± 11.63 | 0.063 |
Male (%) | 21(87.50) | 131(83.44) | 0.771 |
Hypertension (%) | 7(29.17) | 53(33.76) | 0.817 |
Diabetes (%) | 5(20.83) | 34(21.66) | 0.584 |
LM (%) | 1(0.04) | 3(0.02) | 0.437 |
LAD (%) | 13(0.54) | 76(0.48) | 0.664 |
LCX (%) | 0(0) | 17(0.10) | 0.134 |
RCA (%) | 10(0.42) | 60(0.38) | 0.823 |
Heart rate (beats/min) | 75.91 ± 16.71 | 82.50 ± 21.19 | 0.085 |
SBP (mmHg) | 125.90 ± 24.98 | 112.88 ± 30.63 | 0.022 |
DBP (mmHg) | 77.41 ± 16.23 | 72.63 ± 17.70 | 0.185 |
Hospitalization days | 9.71 ± 4.11 | 10.13 ± 7.26 | 0.681 |
Number of stents | 1.43 ± 0.69 | 1.63 ± 0.88 | 0.209 |